Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
09/27 TOBIRA THERAPEU : TBRA) Set to be Acquired by Allergan (AGN) as Ceni..
09/27 ALLERGAN : Receives FDA Approval to Market Natrelle Inspira Breast I..
09/26 ACQUISITION OF : TBRA) Under Investigation for Investors
SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/08/2012 | 12:11am CEST
   By Anjali Athavaley 
   Of  
 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALLERGAN, INC.
09/27 TOBIRA THERAPEUTICS : TBRA) Set to be Acquired by Allergan (AGN) as Cenicriviroc..
09/27 ALLERGAN : Receives FDA Approval to Market Natrelle Inspira Breast Implants
09/26 ACQUISITION OF TOBIRA THERAPEUTICS I : TBRA) Under Investigation for Investors
09/25 5 TOP NASDAQ BIOTECH STOCKS : Tobira Therapeutics Gains 752 Percent
09/25 ALLERGAN : CEO of drugs giant blasts ‘egregious' price hikes
09/24 ALLERGAN : to buy three companies for combined $2.4 billion
09/24 ALLERGAN : CEO of drugmaker blasts 'egregious' price hikes Allergan boss says ph..
09/23 TWO SPECULATIVE NASH ALLOCATIONS POS : AGN)’s Tobira Therapeutics Inc (NAS..
09/23 ALLERGAN : to buy three companies for combined $2.4 billion
09/21 ALLERGAN PLC (NYSE : AGN) Buys Two Biotech Companies In One Day
More news
Sector news : Pharmaceuticals - NEC
09/28DJINTRA CELLULAR THERAPIES : Shares Plunge After Disappointing Drug Trial Results
09/28DJGLAXOSMITHKLINE : to Sell Remaining 6.2% Stake in Aspen Pharmacare
09/28 Monsanto ally Novozymes sees opportunity, risk in Bayer merger
09/27DJPFIZER : Scraps Plan to Break Up Company -- WSJ
09/26DJMYLAN : EpiPen Pretax Profits 60% Higher Than Number Told to Congress -- 3rd Upd..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chairman & President
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Maria Teresa Hilado Director
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON16.06%322 232
ROCHE HOLDING LTD.-12.41%215 081
NOVARTIS AG-10.14%211 231
PFIZER INC.4.80%204 049
MERCK & CO., INC.18.46%171 858
More Results